Its announcement comes within the heels of the same licensing arrangement provided in February to Adastra Labs, which had until now centered on crafting cannabis extracts. Adastra's license also enables it to make and promote psilocybin and psilocin – hallucinogens a lot more normally called magic mushrooms that produce results comparable to LSD.